Correction to “Lenacapavir: Playing the Long Game in the New Era of Antiretrovirals”

IF 6.3 2区医学 Q1 PHARMACOLOGY & PHARMACY

Clinical Pharmacology & Therapeutics Pub Date : 2025-03-16 DOI:10.1002/cpt.3647

引用次数: 0

Abstract

Neverette, N.C., Dumond, J.B., McMahon, D.K. and Devanathan, A.S. (2025), Lenacapavir: Playing the Long Game in the New Era of Antiretrovirals. Clin Pharmacol Ther, 117: 353–367. https://doi.org/10.1002/cpt.3447

In the “Absorption” subsection of the “Clinical Pharmacology Overview” section, the text “The time to maximal concentration (T_max) estimates after oral and SC LEN dosing are 4 hours and 77-84 hours, respectively.” was incorrect. This should have read: “The time to maximal concentration (T_max) estimates after oral and SC LEN dosing are 4 hours and 77-84 days, respectively.” The citation for this statement remains correct.

We apologize for this error.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Pharmacology & Therapeutics 医学-药学

CiteScore

12.70

自引率

7.50%

发文量

290

审稿时长

2 months

期刊介绍： Clinical Pharmacology & Therapeutics (CPT) is the authoritative cross-disciplinary journal in experimental and clinical medicine devoted to publishing advances in the nature, action, efficacy, and evaluation of therapeutics. CPT welcomes original Articles in the emerging areas of translational, predictive and personalized medicine; new therapeutic modalities including gene and cell therapies; pharmacogenomics, proteomics and metabolomics; bioinformation and applied systems biology complementing areas of pharmacokinetics and pharmacodynamics, human investigation and clinical trials, pharmacovigilence, pharmacoepidemiology, pharmacometrics, and population pharmacology.